OKYO Pharma OKYO
NASDAQ OKYO
$1.54 +0.17 (+12.41%)
At close: Oct 21, 2026 · 4:00 PM EDT

OKYO Pharma (OKYO) Change in Receivables (2026)

Updated

OKYO Pharma's Change in Receivables came in at $101,317 for the quarter ended Mar 31, 2026, up 13.2% from the prior quarter.

Analysis

OKYO Pharma (OKYO) Change in Receivables (2026) Analysis & Trends

For the year ended Mar 31, 2026, OKYO Pharma's Change in Receivables was $10,914.

  • Change in Receivables carries a five-year compound annual growth rate of -44.6% (years ended Mar 2021 to Mar 2026).
  • Going back by year, Change in Receivables was -$90,403 in the year ended Mar 31, 2025, $440,257 in the year ended Dec 31, 2024 (+162.5%), $167,718 in the year ended Dec 31, 2023 and -$802,154 in the year ended Mar 31, 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 1.35 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 1.37 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 1.09 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 333.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 OKYO Pharma 1.03 Bn 999.20 Mn - 79,489.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 79,489.00
API Access

OKYO Pharma Change in Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-receivables&ticker=OKYO&period=max&api_key=YOUR_API_KEY